Get started
Gilead Sciences, Inc.
Long

GILD Long

By iktrade
AstrasZeneca deal or possible approvals of its Covid-19 drug Remdesivir may trigger the sharp increase to the upper bound of the daily trend.
SL below daily trend level.
Beyond Technical AnalysisFundamental AnalysisGILDTrend Analysis
iktrade

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.